Literature DB >> 22857759

Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis.

Colin E Champ1, Sarah E Hegarty, Xinglei Shen, Mark V Mishra, Adam P Dicker, Edouard J Trabulsi, Costas D Lallas, Leonard G Gomella, Terry Hyslop, Timothy N Showalter.   

Abstract

OBJECTIVE: To evaluate the prognostic factors and outcomes for a large observational cohort of female patients with urethral cancer in the Surveillance, Epidemiology, and End Results database.
METHODS: We identified 722 women diagnosed with urethral cancer from 1983 to 2008 in the Surveillance, Epidemiology, and End Results database. Descriptive statistics were used to explore the epidemiology, standard treatment practices, and tumor characteristics. A total of 359 women with nonmetastatic primary urethral cancer were identified for cancer-specific and survival analysis. Kaplan-Meier plots and log-rank tests were performed for each potential covariate. A multivariate Cox proportional hazards model was performed to evaluate age, demographic factors, T stage, nodal status, histologic findings, surgery, and radiotherapy.
RESULTS: The median overall survival time was 42 months (95% confidence interval 35-57), and the 5- and 10-year overall survival rate was 43% and 32%, respectively. The median cancer-specific survival (CSS) time was 78 months, and the 5- and 10-year CSS rate was 53% and 46%, respectively. On multivariate analysis, black race, Stage T3-T4 tumors compared with T1, node-positive disease, nonsquamous histologic features, and advanced age were associated with shortened CSS. Surgery was associated with longer CSS. Black patients presented with a statistically significant greater T stage.
CONCLUSION: Advanced age, T stage, node-positive disease, nonsquamous histologic features, and black race were associated with reduced CSS, and surgical resection was associated with longer CSS. We found that black patients present with more advanced tumors and have shorter CSS than white women with urethral cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22857759     DOI: 10.1016/j.urology.2012.02.058

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study.

Authors:  Hao Zi; Lei Gao; Zhaohua Yu; Chaoyang Wang; Xuequn Ren; Jun Lyu; Xiaodong Li
Journal:  Int Urol Nephrol       Date:  2019-10-14       Impact factor: 2.370

2.  Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.

Authors:  Georgios Gakis; Todd M Morgan; Jason A Efstathiou; Kirk A Keegan; Johannes Mischinger; Tilman Todenhoefer; Tina Schubert; Harras B Zaid; Jan Hrbacek; Bedeir Ali-El-Dein; Rebecca H Clayman; Sigolene Galland; Kola Olugbade; Michael Rink; Hans-Martin Fritsche; Maximilian Burger; Sam S Chang; Marko Babjuk; George N Thalmann; Arnulf Stenzl; Siamak Daneshmand
Journal:  World J Urol       Date:  2015-05-17       Impact factor: 4.226

3.  Primary proximal urethral adenocarcinoma: Case report and brief review.

Authors:  Marcos Duarte Siosaki; Roberto Dias Machado; Ana Tarsila Fonseca Souza; Wesley Justino Magnabosco; Alexandre Cesar Santos; Fernando Zapparoli Gonçalves; Fernando Coutinho Pereira; Carlos Flávio de Araújo Silva; Eliney Ferreira Faria
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

4.  Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study.

Authors:  Yong Wei; Yu-Peng Wu; Ning Xu; Xiao-Dong Li; Shao-Hao Chen; Hai Cai; Qing-Shui Zheng; Xue-Yi Xue
Journal:  Onco Targets Ther       Date:  2017-07-10       Impact factor: 4.147

5.  Prognosis of rare pathological primary urethral carcinoma.

Authors:  Mierxiati Abudurexiti; Jun Wang; Ning Shao; Fang-Ning Wan; Yao Zhu; Bo Dai; Ding-Wei Ye
Journal:  Cancer Manag Res       Date:  2018-12-07       Impact factor: 3.989

6.  Comparison Between Urothelial and Non-Urothelial Urethral Cancer.

Authors:  Mike Wenzel; Marina Deuker; Luigi Nocera; Claudia Collà Ruvolo; Zhe Tian; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Andreas Becker; Luis A Kluth; Felix K H Chun; Pierre I Karakiewicz
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

7.  Incidence rates and contemporary trends in primary urethral cancer.

Authors:  Mike Wenzel; Luigi Nocera; Claudia Collà Ruvolo; Christoph Würnschimmel; Zhe Tian; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Derya Tilki; Philipp Mandel; Andreas Becker; Luis A Kluth; Felix K H Chun; Pierre I Karakiewicz
Journal:  Cancer Causes Control       Date:  2021-03-22       Impact factor: 2.506

8.  Survival Outcomes and Predictive Factors for Female Urethral Cancer: Long-term Experience with Korean Patients.

Authors:  Minyong Kang; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

9.  Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival.

Authors:  Ilija Aleksic; Soroush Rais-Bahrami; Michael Daugherty; Piyush K Agarwal; Srinivas Vourganti; Gennady Bratslavsky
Journal:  Urol Ann       Date:  2018 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.